59.下列何者為降血糖藥物canagliflozin的主要作用機轉?
(A)dipeptidyl peptidase 4(DPP-4)抑制劑
(B)glucagon-like peptide-1(GLP-1)受體致效劑
(C)sodium-glucose co-transporter 2(SGLT2)抑制劑
(D)α-glucosidase抑制劑
答案:登入後查看
統計: A(10), B(9), C(63), D(3), E(0) #3490427
統計: A(10), B(9), C(63), D(3), E(0) #3490427
詳解 (共 2 筆)
#7273930
| 選項 | 藥物類別 | 關鍵字尾 | 代表藥物 |
| (A) | DPP-4 抑制劑 | -gliptin | Sitagliptin, Linagliptin |
| (B) | GLP-1 受體致效劑 | -tide | Liraglutide, Dulaglutide |
| (C) | SGLT2 抑制劑 | -gliflozin | Canagliflozin, Empagliflozin, Dapagliflozin |
| (D) | ɑ-Glucosidase 抑制劑 | (無統一字尾) | Acarbose, Miglitol |
| (補充) | TZD 類 (胰島素增敏劑) | -glitazone | Pioglitazone |
0
0